No provisions in USMCA to change U.S. pharmaceutical patent laws: Lighthizer

The United States-Mexico-Canada Agreement has no provisions that would force changes to U.S. laws with respect to pharmaceutical companies, U.S. Trade Representative Robert Lighthizer said on Tuesday.